New ebook now available: Top 10 Pitfalls in Medical Device Development + Tips Download →
The cold has settled in, the first snowflakes have appeared, and Christmas lights are brightening our evenings. There’s no doubt: the year is already coming to an end. And at CLEIO, it flew by, probably because it was a full one. Here’s what we’re taking away from it.
After a more demanding 2024, we approached 2025 with a strong sense of determination. The MedTech market slowed down following the post-pandemic surge, and securing funding became more difficult for many startups. For a company like ours, specializing in medical device development, this context put our balance to the test.
We strengthened our data infrastructure with new tracking methodologies, real-time executive dashboards, and improved monitoring.
We had new talent bringing fresh momentum across our projects and culture.
We closed an important chapter by leaving our Laval office and bringing all Montréal-area teams together in a large open space designed for collaboration, prototyping, and testing, supported by dedicated technical labs.
We expanded our sales force with the addition of Jacob and Joannie.
We rebuilt our marketing strategy from the ground up, boosting channel performance and achieving our strongest results to date.
We took on amazing, high-impact projects in MedTech and other industries.
That’s about the distance between Montreal and Sydney (with a total elevation gain of 168 km, or 19 times the height of Mount Everest)
